梁微微;李乃适;

• 1:中国医学科学院北京协和医学院北京协和医院内分泌科卫生部内分泌重点实验室

摘要(Abstract)：

<正>近年来随着全基因组关联研究(Genome Wide Asso-ciation Study,GWAS)的深入,人们对染色体9p21基因区段的认识大为增加[1-3]。尽管该区段最早在2007年被发现与冠状动脉性心脏病(coronary heart disease,CHD)发病密切相关[1,3],但此后的研究发现9p21区段不仅与2型糖尿病、心肌梗死密切相关,

关键词(KeyWords)： ANRIL;糖脂代谢

Abstract:

Keywords:

基金项目(Foundation): 2014年度留学人员科技活动项目择优资助项目(重点类)

作者(Author): 梁微微;李乃适;

Email:

DOI:

参考文献(References)：

• [1]Helgadottir A,Thorleifsson G,Manolescu A,et al.A common variant on chromosome 9p21 affects the risk of myocardial infarction[J].Science,2007,316:1491-1493.
• [2]Saxena R,Voight BF,Lyssenko V,et al.Genome-wide association study of 14 000 cases of seven common diseases and3,000 shared controls[J].Nature,2007,447:661-678.
• [3]Mc Pherson R,Pertsemlidis A,Kavaslar N,et al.A common allele on chromosome 9 associated with coronary heart disease[J].Science,2007,316:1488-1491.
• [4]Pasmant E,Sabbagh A,Vidaud M,et al.ANRIL,a long,noncoding RNA,is an unexpected major hotspot in GWAS[J].FASEB J,2011,25:444-448.
• [5]Pasmant E,Laurendeau I,Heron D,et al.Characterization of a germ-line deletion,including the entire INK4/ARF locus,in a melanoma-neural system tumor family:identification of ANRIL,an antisense noncoding RNA whose expression coclusters with ARF[J].Cancer Res,2007,67:3963-3969.
• [6]Canepa ET,Scassa ME,Ceruti JM,et al.INK4 proteins,a family of mammalian CDK inhibitors with novel biological functions[J].IUBMB Life,2007,59:419-426.
• [7]Matheu A,Maraver A,Collado M,et al.Anti-aging activity of the Ink4/Arf locus[J].Aging Cell,2009,8:152-161.
• [8]Yap KL,Li S,Munoz-Cabello AM,et al.Molecular interplay of the noncoding RNA ANRIL and methylated histone H3lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a[J].Mol Cell,2010,38:662-674.
• [9]El Messaoudi-Aubert S,Nicholls J,Maertens GN,et al.Role for the MOV10 RNA helicase in polycomb-mediated repression of the INK4a tumor suppressor[J].Nat Struct Mol Biol,2010,17:862-868.
• [10]Popov N,Gil J.Epigenetic regulation of the INK4b-ARFINK4a locus:in sickness and in health[J].Epigenetics,2010,5:685-690.
• [11]Yu W,Gius D,Onyango P,et al.Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA[J].Nature,2008,451:202-206.
• [12]Kotake Y,Nakagawa T,Kitagawa K,et al.Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B)tumor suppressor gene[J].Oncogene,2011,30:1956-1962.
• [13]Sato K,Nakagawa H,Tajima A,et al.ANRIL is implicated in the regulation of nucleus and potential transcriptional target of E2F1[J].Oncol Rep,2010,24:701-707.
• [14]Johnson AD,Hwang SJ,Voorman A,et al.Resequencing and clinical associations of the 9p21.3 Region:A comprehensive investigation in the Framingham Heart Study[J].Circulation,2013,127:799-810.
• [15]Jarinova O,Stewart AF,Roberts R,et al.Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus[J].Arterioscler Thromb Vasc Biol,2009,29:1671-1677.
• [16]Holdt LM,Beutner F,Scholz M,et al.ANRIL expression is associated with atherosclerosis risk at chromosome 9p21[J].Arterioscler Thromb Vasc Biol,2010,30:620-627.
• [17]Gizard F,Amant C,Barbier O,et al.PPAR alpha inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a[J].J Clin Invest,2005,115:3228-3238.
• [18]Visel A,Zhu Y,May D,et al.Targeted deletion of the 9p21non-coding coronary artery disease risk interval in mice[J].Nature,2010,464:409-412.
• [19]Saxena R,Voight BF,Lyssenko V,et al.Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels[J].Science,2007,316:1331-1336.
• [20]Zeggini E,Weedon MN,Lindgren CM,et al.Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes[J].Science,2007,316:1336-1341.
• [21]Scott LJ,Mohlke KL,Bonnycastle LL,et al.A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants[J].Science,2007,316:1341-1345.
• [22]Peng F,Hu D,Gu C,et al.The relationship between five widely-evaluated variants in CDKN2A/B and CDKAL1 genes and the risk of type 2 diabetes:a meta-analysis[J].Gene,2013,531:435-443.
• [23]Al-Sinani S,Woodhouse N,Al-Mamari A,et al.Association of gene variants with susceptibility to type 2 diabetes among Omanis[J].World J Diabetes,2015,6:358-366.
• [24]Krishnamurthy J,Torrice C,Ramsey MR,et al.Ink4a/Arf expression is a biomarker of aging[J].J Clin Invest,2004,114:1299-1307.
• [25]Fajas L,Blanchet E,Annicotte JS.CDK4,pRB and E2F1:connected to insulin[J].Cell Div,2010,5:6.
• [26]Dagenais M,Skeldon A,Saleh M.The inflammasome:in memory of Dr.Jurg Tschopp[J].Cell Death Differ,2012,19:5-12.
• [27]Bantubungi K,Hannou SA,Caron-Houde S,et al.Cdkn2a/p16Ink4a regulates fasting-induced hepatic gluconeogenesis through the PKA-CREB-PGC1alpha pathway[J].Diabetes,2014,63:3199-3209.
• [28]Ahmed W,Ali IS,Riaz M,et al.Association of ANRIL polymorphism(rs1333049:C>G)with myocardial infarction and its pharmacogenomic role in hypercholesterolemia[J].Gene,2013,515:416-420.
• [29]Hrdlickova B,de Almeida RC,Borek Z,et al.Genetic variation in the non-coding genome:Involvement of micro-RNAs and long non-coding RNAs in disease[J].Biochim Biophys Acta,2014,1842:1910-1922.